Article info

Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design

Authors

  1. Correspondence to Dr Yongjun Wang; yongjunwang{at}ncrcnd.org.cn
View Full Text

Citation

Li S, Campbell BCV, Schwamm LH On behalf of the TRACE II investigatiors, et al
Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design

Publication history

  • Received April 23, 2021
  • Accepted August 2, 2021
  • First published August 26, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.